NCT02612337View on ClinicalTrials.gov

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

October 27, 2015

Primary Completion Date

July 18, 2017

Study Completion Date

July 18, 2017

Conditions
Meniere's Disease
Interventions
DRUG

OTO-104

Single intratympanic injection of 12 mg OTO-104

DRUG

Placebo

Single intratympanic injection of placebo

Trial Locations (1)

Unknown

Many sites in US. Refer to the contact info listed below., San Diego

Sponsors

Lead Sponsor

Otonomy, Inc.
All Listed Sponsors
lead

Otonomy, Inc.

INDUSTRY